| 貨號(hào) |
中文名稱 |
英文名詞 |
靶點(diǎn) |
|
VAPD00144 |
替奈昔單抗
|
Research Grade Teneliximab Biosimilar? |
CD40, TNFRSF5,B-cell surface antigen CD40 |
|
VAPD00143 |
依美昔單抗
|
Research Grade Ecromeximab Biosimilar? |
Disialoganglioside GD3, GD3 ganglioside, α-N-acetylneuraminosyl-(2→8)-α-N-acetylneuraminosyl-(2→3)-β |
|
VAPD00142 |
Research Grade tositumomab Biosimilar?
|
|
MS4A1, CD20, B-lymphocyte antigen CD20 |
|
VAPD00141 |
Research Grade epitumomab cituxetan Biosimilar?
|
|
MUC1, MUC-1, PEM, PUM, PEMT, H23AG, EMA, CD227, Mucin-1, |
|
VAPD00140 |
Research Grade Epitumomab ( 西依匹莫單抗 ) Biosimilar?
|
|
MS4A1, CD20, B-lymphocyte antigen CD20 |
|
VAPD00139 |
艾西莫單抗
|
Research Grade Elsilimomab Biosimilar? |
IL6, IFNB2, BSF-2, CDF, Interleukin-6, IL-6, IFN-beta-2 |
|
VAPD00138 |
貝利木單抗
|
Research Grade Belimumab Biosimilar? |
TNFSF13B, BAFF, BLyS, TALL-1, TNFSF20, ZTNF4, CD257 |
|
VAPD00137 |
烏珠單抗
|
Research Grade Urtoxazumab ( 烏珠單抗 ) Biosimilar? |
shiga toxin type 2, stx2, Stx2, Stx-2, Shiga-like toxin 2 |
|
VAPD00136 |
利韋單抗
|
Research Grade Libivirumab ( 利韋單抗 ) Biosimilar? |
HBV (hepatitis B virus) surface antigen (HBsAg) [Hepatitis B virus]? |
|
VAPD00135 |
艾韋單抗
|
Research Grade Exbivirumab Biosimilar? |
HBV (hepatitis B virus) surface antigen (HBsAg) [Hepatitis B virus]? |
